Wednesday, September 23, 2026

Qiagen N.V. And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Qiagen N.V. And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

2. E.W. Scripps Company

51.1% sales growth and 14.9% return on equity

The E.W. Scripps Company, together with its subsidiaries, operates as a media enterprise through a portfolio of local and national media brands.

E.W. Scripps Company's sales growth this year is anticipated to be 21.8% and 15.3% for next year.

Year-on-year quarterly revenue growth grew by 39.7%, now sitting on 1.86B for the twelve trailing months.

E.W. Scripps Company's sales growth for the next quarter is 51.1%. The company's growth estimates for the ongoing quarter and the next is 220% and 177.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.9%.

Volatility

E.W. Scripps Company's last day, last week, and last month's current volatility was 1.52%, 0.95%, and 2.16%, respectively.

E.W. Scripps Company's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.41% (day), 3.40% (last week), and 4.97% (last month), respectively.

E.W. Scripps Company's Stock Yearly Top and Bottom Value

E.W. Scripps Company's stock is valued at $20.69 at 23:22 EST, way under its 52-week high of $24.78 and way above its 52-week low of $5.84.

E.W. Scripps Company's Moving Average

E.W. Scripps Company's worth is under its 50-day moving average of $21.10 and way above its 200-day moving average of $15.32.

3. II-VI Incorporated

7% sales growth and 7.22% return on equity

II-VI Incorporated develops, manufactures, and markets engineered materials, and optoelectronic components and devices worldwide.

II-VI Incorporated's sales growth this year is expected to be 29.6% and 10.7% for next year.

Year-on-year quarterly revenue growth grew by 18%, now sitting on 2.89B for the twelve trailing months.

II-VI Incorporated's sales growth for the next quarter is 7%. The company's growth estimates for the current quarter and the next is 87.2% and negative -22.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.22%.

Volatility

II-VI Incorporated's last day, last week, and last month's current volatility was 2.52%, 2.83%, and 2.89%, respectively.

II-VI Incorporated's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.99% (day), 3.04% (last week), and 4.90% (last month), respectively.

II-VI Incorporated's Stock Yearly Top and Bottom Value

II-VI Incorporated's stock is valued at $76.22 at 23:22 EST, way below its 52-week high of $100.44 and way higher than its 52-week low of $26.55.

II-VI Incorporated's Moving Average

II-VI Incorporated's worth is higher than its 50-day moving average of $75.47 and way above its 200-day moving average of $68.77.

4. New York Community Bancorp, Inc.

20.6% sales growth and 7.54% return on equity

New York Community Bancorp, Inc. operates as a bank holding company for New York Community Bank that provides banking products and services in Metro New York, New Jersey, Ohio, Florida, and Arizona.

New York Community Bancorp, Inc.'s sales growth this year is anticipated to be 16% and 7.5% for next year.

Year-on-year quarterly revenue growth grew by 20.8%, now sitting on 1.1B for the twelve trailing months.

New York Community Bancorp, Inc.'s sales growth for the next quarter is 20.6%. The company's growth estimates for the ongoing quarter and the next is 35% and 33.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.54%.

Volatility

New York Community Bancorp, Inc.'s last day, last week, and last month's current volatility was 0.40%, 0.46%, and 1.29%, respectively.

New York Community Bancorp, Inc.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.52% (day), 1.99% (last week), and 2.60% (last month), respectively.

New York Community Bancorp, Inc.'s Stock Yearly Top and Bottom Value

New York Community Bancorp, Inc.'s stock is valued at $12.54 at 23:22 EST, below its 52-week high of $13.23 and way higher than its 52-week low of $7.72.

New York Community Bancorp, Inc.'s Moving Average

New York Community Bancorp, Inc.'s value is above its 50-day moving average of $12.27 and way higher than its 200-day moving average of $10.27.

5. Graco Inc.

22.3% sales growth and 28.62% return on equity

Graco Inc. designs, manufactures, and markets systems and equipment used to move, measure, control, dispense, and spray fluid and powder materials worldwide.

Graco Inc.'s sales growth this year is anticipated to be 10.5% and 5.5% for next year.

Year-on-year quarterly revenue growth grew by 14.1%, now sitting on 1.65B for the twelve trailing months.

Graco Inc.'s sales growth for the next quarter is 22.3%. The company's growth estimates for the ongoing quarter and the next is 31.6% and 48.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 28.62%.

Volatility

Graco Inc.'s last day, last week, and last month's current volatility was 0.82%, 0.61%, and 0.98%, respectively.

Graco Inc.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.28% (day), 1.37% (last week), and 1.98% (last month), respectively.

Graco Inc.'s Stock Yearly Top and Bottom Value

Graco Inc.'s stock is valued at $74.08 at 23:22 EST, below its 52-week high of $76.98 and way above its 52-week low of $41.79.

Graco Inc.'s Moving Average

Graco Inc.'s value is above its 50-day moving average of $70.00 and above its 200-day moving average of $68.78.

6. Qiagen N.V.

33.4% sales growth and 13.47% return on equity

QIAGEN N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide.

Qiagen N.V.'s sales growth this year is anticipated to be 21.2% and a negative 3.4% for next year.

Year-on-year quarterly revenue growth grew by 38.2%, now sitting on 1.87B for the twelve trailing months.

Qiagen N.V.'s sales growth for the next quarter is 33.4%. The company's growth estimates for the present quarter and the next is 85.3% and 14.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.47%.

Volatility

Qiagen N.V.'s last day, last week, and last month's current volatility was 0.19%, 0.88%, and 1.25%, respectively.

Qiagen N.V.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.70% (day), 1.06% (last week), and 1.80% (last month), respectively.

Qiagen N.V.'s Stock Yearly Top and Bottom Value

Qiagen N.V.'s stock is valued at $51.29 at 23:22 EST, way below its 52-week high of $59.00 and way above its 52-week low of $39.05.

Qiagen N.V.'s Moving Average

Qiagen N.V.'s value is higher than its 50-day moving average of $49.99 and above its 200-day moving average of $51.05.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Frontier AI Slowdown Call Splits Industry, Rattles Capex-Sensitive Markets
Anthropic's Dario Amodei publicly called for a coordinated global slowdown in frontier AI development, a stance Microsoft echoed with a 'humanist' AI code of conduct, but Nvidia and Meta's CEOs rejected any coordinated pause days later, exposing a widening rift between safety-focused and growth-focused AI leaders. The dispute landed amid growing financial scrutiny of AI infrastructure spending — a hyperscaler capex analysis, FTC warnings against antitrust waivers for AI firms, and an 8.6% single-day stock drop in GE Vernova tied directly to the slowdown remarks — signaling investors are newly nervous about whether the AI capex boom (including Alphabet's projected $701B revenue narrative) can be justified if the pace of development itself becomes contested.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,983
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,983 facts checked against source5,304 source documents archived
Query this data → isubstrate.com